Cargando…
Breslow thickness 2.0: Why gene expression profiling is a step toward better patient selection for sentinel lymph node biopsies
Risk-stratification of cutaneous melanoma is important. Patients want to know what to expect after diagnosis, and physicians need to decide on a treatment plan. Historically, melanoma that had spread beyond the skin and regional lymph nodes was largely incurable, and the only approach to preventing...
Autores principales: | Sadurní, Mariana B., Meves, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162102/ https://www.ncbi.nlm.nih.gov/pubmed/35654998 http://dx.doi.org/10.1038/s41379-022-01101-y |
Ejemplares similares
-
Using the Merlin assay for reducing sentinel lymph node biopsy complications in melanoma: a retrospective cohort study
por: Hieken, Tina J., et al.
Publicado: (2022) -
Sentinel Lymph Node Biopsy in Patients With Thick Primary Cutaneous Melanoma
por: Rodriguez Otero, Juan Carlos, et al.
Publicado: (2019) -
Cost evaluation of the Merlin assay for predicting melanoma sentinel lymph node biopsy metastasis
por: Thao, Viengneesee, et al.
Publicado: (2022) -
Deselecting Melanoma Patients for Sentinel Lymph Node Biopsy During COVID-19: Clinical Utility of Tumor Molecular Profiling
por: Meves, Alexander, et al.
Publicado: (2020) -
Sentinel lymph node biopsy for high-thickness cutaneous squamous cell carcinoma
por: Kofler, Lukas, et al.
Publicado: (2020)